Prognostic value of GPC5 polymorphism rs2352028 and clinical characteristics in Chinese lung cancer patients

Future Oncol. 2022 Sep;18(28):3165-3177. doi: 10.2217/fon-2022-0319. Epub 2022 Sep 27.

Abstract

Background: GPC5 rs2352028 is associated with the risk of lung cancer, but its relationship with lung cancer prognosis is unclear. Materials & methods: The authors collected blood samples from 888 patients with lung cancer and used a Cox proportional hazards model to analyze the association between prognosis and GPC5 polymorphism rs2352028. Results: GPC5 rs2352028 C > T was associated with a better prognosis. Patients with CT genotype had longer overall survival than those with CC genotype. Additionally, older and early-stage patients with CT + TT genotype had a lower risk of death than those with CC genotype. Conclusion: GPC5 rs2352028 C > T may play a protective role in patients with lung cancer and GPC5 rs2352028 may be a potential genetic marker for lung cancer prognosis.

Keywords: GPC5; lung cancer; prognosis; single nucleotide polymorphism; smoking.

MeSH terms

  • China / epidemiology
  • Genetic Markers
  • Genetic Predisposition to Disease*
  • Genotype
  • Glypicans / genetics
  • Humans
  • Lung Neoplasms* / genetics
  • Polymorphism, Single Nucleotide
  • Prognosis

Substances

  • GPC5 protein, human
  • Genetic Markers
  • Glypicans